We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial. Interview Questions: 1. What is…
Read More »Cardiology
Harlan Krumholz, MD, FACC, Editor-in-Chief of JACC emphasizes that JACC focuses on making a real impact rather than just chasing impact factors. Dr. Krumholz reiterates that JACC aims to be…
Read More »
Aakriti Gupta, MD, FACC, JACC Executive Associate Editor, and Stefan D. Anker, MD discuss the insights from the RESHAPE-HF2 trial — an eight-year study on the efficacy of transcatheter edge-to-edge…
Read More »
Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ Visit Radcliffe Vascular: https://www.radcliffevascular.com/ This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the…
Read More »
Khurram Nasir, MBBS, FACC, JACC Associate Editor and Tor Biering-Sorenson, MD, MPH, PhD, discuss the importance of influenza vaccines for patients with chronic kidney disease (CKD), particularly in the context…
Read More »
The MGB Heart Failure & Shock symposium will provide practical insights for all clinicians who manage patients with heart failure (HF) and cardiogenic shock. The first half of the course…
Read More »
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique. Dr Harriette Van Spall (McMaster University, CA) sits down with…
Read More »
EuroPCR 2024 – We are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA) for a concise and insightful summary of the late-breaking trials that are expected to…
Read More »
Michelle M. Kittleson, MD, PhD, FACC, JACC Associate Editor and John A. Spertus, MD, MPH, FACC discuss the evaluation of the cardiac myosin inhibitor, aficamten, on patient-reported health status in…
Read More »
FFR-guided PCI improves outcomes in TAVI patients with coronary artery disease. Principal investigator, Prof Jacob Thomsen Lønborg (Rigshospitalet, DK) joins us to discuss the NOTION-3 trial (NCT03058627). A multinational, open-label,…
Read More »